[1] |
Wasinger V C, Humphery Smith I, Willams K L,et al. Progress with gene product mapping of the molicutes: Mycoplasma genitalium. Electrophoresis,1995,16:1090 -1094.
|
[2] |
Anderson N L, Anderson N G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics,2002,1:845 -867.
|
[3] |
Putnam F W. Perspectives past, present and future. In: Putnam FW, ed. The plasma proteins structure, function, and genetic control. New York Academic Press,(1975 -1987):1 -55.
|
[4] |
Cohn E J. The history of plasma fractionation. Advances in Military Medicine,1948,1:364 -443.
|
[5] |
Kohler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature,1975,256:49 -57.
|
[6] |
Pieper R, Su Q, Gatlin C L,et al. Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome. Proteomic,2003,3:422 -432.
|
[7] |
Georgiou H M, Rice G E, Baker M S. Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins. Proteomics,2001,1:1503 -1506.
|
[8] |
Tirumalai R S, Chan K C, Prieto D A,et al. Characterization of the low molecular weight human serumproteome. Mol Cell Proteomics,2003,2:1096 -1103.
|
[9] |
Steel L F, Trotter M G, Nakajima P B,et al. Efficient and specific removal of albumin from human serum samples. Mol Cell Proteomics,2003,2:262 -270.
|
[10] |
Zuo X, Speicher D W. Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two -dimensional electrophoresis. Proteomics,2002,2:58 -68.
|
[11] |
Adkins J N, Varnum S M, Auberry K J,et al. Toward a human blood serumproteome: analysis by multi - dimensional separation coupled with mass spectrometry. Mol Cell Proteomics,2002,1:947-955.
|
[12] |
O'Farrell P H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem,1975,250:4007 -4021.
|
[13] |
Stuhler K, Meyer H E. MALDI: more than peptide mass fingerprints. Curr Opin Mol Ther,2004,6:239 -248.
|
[14] |
Conrads T P,Hood B L,Issaq H J,et al. Proteomic patterns as a diagnostic tool for early-stage cancer: a review of it s progress to a clinically relevant tool. Mol Diagn,2004,8:77 -85.
|
[15] |
Issaq H J, Veenstra T D, Conrads T P, et al. The SELDI-TOF MS approach to proteomics:protein profiling and biomarker identification. Biochem Biophys Res Commun,2002,292:587 -592.
|
[16] |
Wall D B,Berger S J, Finch J W,et al. Continuous sample deposition from reversed-phase liquid chromatography to tracks on a matrix-assisted laser desorption/ionization precoated target for the analysis of protein digests. Electrophoresis,2002,23:3193 -3204.
|
[17] |
Macbeat H G, Schreiber S L. Printing proteins as microarrays for high - throughput function determination. Science,2000,278(5485):1760 -1763.
|
[18] |
O'Donovan C, Apweiler R, Bairoch A. The human proteomics initiative (HPI). Trends Biotechnol,2001,19:178 -181.
|
[19] |
Berman H M, Westbrook J, Feng Z, et al. The protein data bank. Nucleic Acids Res,2000,28:235 -242..
|
[20] |
Bairoch A, Apweiler R. The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000. Nucleic Acids Research,2000,28:45 -48.
|
[21] |
Kawashima S,Kanehisa M. AAindex:amino acid index database.Nucleic Acids Res,2000,28(1):374.
|
[22] |
Gavin A C, Bosche M, Krause R,et al. Functional organization of t he yeast proteome by systematic analysis of protein complexes.Nature,2002,415:141 -147..
|
[23] |
Ho Y, Gruhler A, Bader G D,et al. Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry. Nature,2002,415:180 -183.
|
[24] |
Wulfkuhle J D, Sgroi D C, Krutzsch H,et al. Proteomics of humanbreast ductal carcinorma in situ. Cancer Res,2002,62:6740-6749..
|
[25] |
Jungblut P R, Zimny-Arndt U, Zeindl-Eberhart E, et al. Proteomics in human disease: cancer, heart and infectious disease.Electrophoresis,1999,20(10):2100 -2110.
|
[26] |
Prasannan L, Misek D E, Hinderer R,et al. Identification of betatubulin isoforms as tumour antigens in neuroblastoma. Clin Cancer Res,2000,6:3949 -3956..
|
[27] |
Chen G, Gharib T G, Huang C C, et al. Proteomic analysis of lung adenocarcinoma: identification of a highly expressed set of proteins in tumors. Clin Cancer Res,2002,8:2298 -2305..
|
[28] |
Birchory F, Beer D, Hanash S,et al. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. Cancer Research,2001,61:7908 -7912..
|
[29] |
Adam B L, Qu Y, Davis J W,et al. Serum protein fingerprinting coupled with a patternmatching algorithm distinguishes prostate cancer from benign prostate hyperp lasia and healthy men. Cancer Res,2002,62:3609 -3614.
|
[30] |
Bergman A C,Benjamin T,Alaiya A. Identification of gel-separated tumor marker protein by mass spectrometry. Electrophoresis,2000,21:679.
|
[31] |
Alaiya A A, Franen B, Auer G,et al. Cancer proteomics: from identification of novel markers to creation of artifical learning models for tumor classification. Electrophoresis,2000,21:1210.
|
[32] |
Smith R A, Cokkinides V, Eyre H J. American cancer society guidelines for the early detection of cancer. CA Cancer J Clin,2003,53:27.
|
[33] |
Petricoin E F,Liotta L A. Proteomic analysis at the bedside:early detection of cancer. Trends Biotechnol,2002,12:S30.
|
[34] |
Hu Y, Zhang S, Yu J, et al. SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.Breast,2005,14:250 -255.
|
[35] |
Stierum R, Gaspari M, Dommels Y,et al. Proteome analysis reveal novel proteins associated with proliferation anddifferentiation of the colorectal cancer cell line Caco-2. Biochim Biophys Acta,2003,1605:73.
|
[36] |
Melhem R, Hailat N, Kuick R, et al. Quantitative analysis of Op18 phosphorylation in childhood acute leukemia. Leukemia,1997,11:1690.
|
[37] |
Sinha P,Kohl S,Fischer J. Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two - dimensional electrophoresis. Electrophoresis,2000,21:3048.
|
[38] |
Chen S T, Pan T L, Tsai Y C,et al. Proteomics reveals protein profile changes in doxorubicin treated MCF 27 human breast cancer cells. Cancer Lett,2002,181:95 -107.
|
[39] |
Ross J S, Fletcher J A, Bloom K J, et al. Targeted therapy in breast cancer: the HER-2/neu gene and protein. Mol Cell Proteomics,2004,3:379 -398.
|
[40] |
Venter J C, Adams M D, Myers E W,et al. The sequence of the human genome. Science,2001,291:1304 -1351.
|
[41] |
Abbott A. And now for the proteome. Nature,2001,409:747.
|
[42] |
Fields S. Proteomics in genomeland. Science,2001,291:122.
|